This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Atreya R, Mudter J, Finotto S, et al (2000) Blockade of IL-6 trans-signaling suppresses T cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn’s disease and experimental colitis in vivo. Nat Med 6:583–588
Boirivant M, Fuss IJ, Chu A, Strober W (1998) Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin-4. J Exp Med 188:1929–1939
Christ AD, Stevens AC, Koeppen H, Walsh S, Omata F, Devergne O, Birkenbach M, Blumberg RS (1998) An interleukin 12-related cytokine is up-regulated in ulcerative colitis but not in Crohn’s disease. Gastroenterology 115:307–313
Duchmann R, Zeitz M (1998) Crohn’s disease. In: Ogra P, Strober W (eds) Handbook of mucosal immunology. Academic Press, New York
Elson CO (2002) Genes, microbes, and T cells — new therapeutic targets in Crohn’s disease. New Engl J Med 346:614–616
Elson CO, Sartor RB, Tennyson GS, Riddell RH (1995) Experimental models of inflammatory bowel disease. Gastroenterology 109:1344–1367
Emmrich J, Seyfarth M, Fleig W, Emmrich F (1991) Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody. Lancet 338: 570–571
Fuss I, Neurath MF, Boirivant M, Klein JS, Motte CD, Strong SA, Fiocchi C, Strober W (1996) Disparate CD4+ lamina propria (LP) lymphocyte secretion profiles in inflammatory bowel disease. J Immunol 157:1261–1270
Fuss IJ, Marth T, Neurath MF, Pearlstein GR, Jain A, Strober W (1999) Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology 117:1078–1088
Hove TT, Montfrans CV, Peppelenbosch MP, Deventer SJv (2002) Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn’s disease. Gut 50:206–211
Kuhn R, Lohler J, Rennick D, Rajewsky K, Mueller W (1993) Interleukin-10 deficient mice develop chronic enterocolitis. Cell 75:263–274
Mizoguchi A, Mizoguchi E, Chiba C, Bhan AK (1996) Role of appendix in the development of inflammatory bowel disease in TCR-α mutant mice. J Exp Med 184:707–715
Mizoguchi A, Mizoguchi E, Smith RN, Preffer FI, Bhan AK (1997) The suppressive role of B cells in chronic colitis of T cell receptor α mutant mice. J Exp Med 186:1749–1756
Mizoguchi A, Mizoguchi E, Bhan AK (1999) The critical role for interleukin-4 but not interferon-γ in the pathogenesis of colitis in T-cell receptor α mutant mice. Gastroenterology 116:320–326
Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F, Pallone F (1997) Interleukin-12 is expressed and actively released by Crohn’s disease intestinal lamina propria mononuclear cells. Gastroenterology 112:1169–1178
Monteleone G, MacDonald TT, Wathen NC, Pallone F, Pender SL (1999) Enhancing Lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury. Gastroenterology 117:1069–1077
Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W (1995) Antibodies to IL-12 abrogate established experimental colitis in mice. J Exp Med 182:1280–1289
Neurath MF, Duchmann R, Büschenfelde KHMz (1996) Zytokine bei chronisch entzündlichen Darmerkrankungen. DMW 121:735–741
Neurath MF, Finotto S, Strober W (2001) Immunology of inflammatory bowel disease. Chap. 87: Clinical Immunology, 2nd edn. In press
Neurath MF, Finotto S, Glimcher LH (2002a) The role of Th1/Th2 polarization in mucosal immunity. Nat Med 8:567–573
Neurath MF, Weigmann B, Finotto S, et al (2002b) The transcription factor T-β regulates mucosal T cell activation in experimental colitis and Crohn’s disease. J Exp Med 195:1129–1143
Oppmann B, Lesley R, Blom B et al (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar to as well as distinct from IL-12. Immunity 13(5):715–725
Podolsky DK (1991) Inflammatory bowel disease. New Engl J Med 325: 928–937
Powrie F, Maloy KJ (2003) Regulating the regulators. Science 299:1030–1031
Powrie F, Leach MW, Mauze S, Menon S, Caddie LB, Coffman RL (1994) Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 2:553–562
Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL (1996) A critical role for transforming growth factor-β but not interleukin-4 in the suppression of T helper type 1-mediated colitis by CD45Rb(low) CD4+ T cells. J Exp Med 183:2669–2674
Schunk K, Kern A, Oberholzer K, Kalden P, Orth T, Mayer I, Wanitschke R (2000) Hydro-MRI in Crohn’s disease: Appraisal of disease activity. Invest Radiol 35:431–437
Simpson SJ, Shah S, Comiskey M, de-Jong VP, Wang B, Mizoguchi E, Bhan AK, Terhorst C (1998) T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon γ expression by T cells. J Exp Med 187:1225–1234
Spencer DM, Veldman GM, Banerjee S, Willis J, Levine AD (2002) Distinct inflammatory mechanisms mediate early versus late colitis in mice. Gastroenterology 122:94–105
Strober W, Neurath MF (1995) Immunological diseases of the gastrointestinal tract. In: Rich RR (ed) Clinical immunology, Chap. 94. Mosby, St. Louis, pp 1401–1428
Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, Neurath MF (1997) Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation. Immunol Today 18:61–64
Stüber E, Strober W, Neurath MF (1996) Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of Th1-T cells through the inhibition of IL-12 secretion. J Exp Med 183:693–698
Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655–669
Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH (2002) T-bet is essential for Th1 lineage commitment and IFN-γ production in CD4 but not CD8 T Cell. Sci 295:338–342
Targan SR, Hanauer SB, Deventer SJV, Mayer L, Present DH, Braakman T, Woody KLD, Schaible TF, Rutgeerts PJ (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn’s disease. New Engl J Med 337:1029–1035
Wirtz S, Neurath MF (2000) Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int J Colorectal Dis 15:144–160
Wirtz S, Finotto S, Kanzler S, Lohse AW, Blessing M, Lehr HA, Galle PR, Neurath MF (1999) Cutting Edge: Chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF-plus IFN-γ producing CD4+ T cells that respond to bacterial antigens. J Immunol 162:1884–1888
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Neurath, M.F. (2005). Animal Models of Inflammatory Bowel Diseases. In: Zollner, T., Renz, H., Asadullah, K. (eds) Animal Models of T Cell-Mediated Skin Diseases. Ernst Schering Research Foundation Workshop, vol 50. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26811-1_6
Download citation
DOI: https://doi.org/10.1007/3-540-26811-1_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21067-2
Online ISBN: 978-3-540-26811-6
eBook Packages: MedicineMedicine (R0)